Medicines Policies

last updated 15/01/2026

Policies relating to the management of medicines, and the terms of reference of ADTC and other groups in the medicines advisory structure are noted in this section.  The information contained at this site is issued on the understanding that it is the best available from the resources at our disposal at the time of issue.

		Expiry Date or Comments
	Structure and General
1.1	Medicines Advisory Structure	Under review Nov 25
1.2	Managed Entry of New Medicines	Oct 2027
1.3	Managed Introduction of New Oncology Medicines	Under review  Nov 25
	ADTC and Subcommittees
2.1	Area Drug and Therapeutics Committee: Terms of Reference	Oct 2026
2.2	Medicines Utilisation Subcommittee: Terms of Reference	Jan 2028
2.3	Prescribing Interface Subcommittee: Terms of Reference	March 2027
2.4	Non-Medicines Utilisation Subcommittee: Terms of Reference	June 2028
2.4.1	Processes related to the Non-Medicines Formularies	April 2027
2.4.2	Non-Medicines Utilisation Sub-Committee Guideline/ Formulary Checklist	Under review Sept 2021
2.5	Communications Subcommittee: Terms of Reference	May 2027
2.6	Antimicrobial Utilisation Subcommittee: Terms of Reference	Aug 2027
2.7	Safer Use of Medicines Subcommittee: Terms of Reference	Oct 2026
2.8	Patient Group Direction Subcommittee: Terms of Reference	Oct 2026
	Formulary Management
3.1	Formulary Management Policy  You may also wish to refer to 3.1.1 Formulary Processes for Medical Devices, Non-Prescription Only Medicines (non-POMs) and Complimentary Medicines	Jan 2027
	Prescribing Management Group (PMG) and Subgroups
4.2	Acute Services PMG: Terms of Reference	Jan 2019
4.3	Primary Care PMG: Terms of Reference	Dec 2026
4.5	PMG Mental Health: Terms of Reference	Sept 2020
	Access to Medicines
5.1	Non-Formulary Prescribing Policy	Aug 2028
5.2	Peer Approved Clinical System (PACS Tier Two) Policy For related info and documentation, see HERE	Dec 2028
5.4	Management of Individual Patient Treatment Requests (IPTRs)	Dec 2028
5.5	Individual Patient Treatment Request (IPTR) Appeal process	Dec 2028
5.6	Co-Payment Policy	Oct 2028
5.6.1	Co-Payment Form (CPF1)	Oct 2028
5.7	Acute Unlicensed Medicines Policy (ULM Policy)	Jan 2027
5.8	Guidance for Medicines Access Schemes	Oct 2028
5.9	Ultra-Orphan Pathway	New: in development Nov 25
5.10	Supply of Medicines Following Specialist Review or Clinic Appointments	May 2028
5.10.1	Supply of Medicines Following Specialist Review - Additional Guidance for Mental Health	Aug 2027
	Clinical and Handling of Medicines Policies
6.1	Safe and Secure Handling of Medicines Policy and Guidance
6.2A	Administration of Intravenous (IV) Medicines and Flush Policy	Via Clinical Guidelines
6.2B	Addendum to Administration of IV Medicines and Flush Policy	Sept 2026
6.4	Policy for Non-Cytotoxic Intrathecal and Intraventricular Injections	Under review  Nov 2025
6.4.1	Register of Authorised Non-Cytotoxic Intrathecal and Intraventricular Injections (Nov 2022)	Under review Nov 2025
6.5	Medicines Reconciliation in Hospital	March 2028
	Clinical Guidelines
7.1	Clinical Guidelines Framework	Via Clinical Guidelines
7.2	Development and Review Process and Clinical Guideline Title Page	Via Clinical Guidelines
7.3	Electronic Checklists for submission of Clinical Guidelines	Via Clinical Guidelines
7.4	AUC Antimicrobial Guideline Approval Process	Aug 2027
	Miscellaneous
8.1	Suspected Medicines Defect Policy	Nov 2027
8.1.1	Suspected Medicines Defect Reporting Form (for use by acute pharmacy staff)	Nov 2027
8.2	Symptomatic Relief Policy (Adults)	Sept 2028
8.3	Medicines Alert and recall policy NHSGGC chain of communications relating to medicines alerts	May 2027
8.4	PPSU Medicines Shortages Guidance via StaffNet	Under review 2021
8.4.1	Patient Group Directions: Management of medicines shortages	Dec 2027
8.4.2	Primary Care Medicine Shortage Guidance	Apr 2028
8.5.1	Non-medical prescribing policy	Apr 2028
8.5.2	Non-medical prescribing guidance	June 2028